[#item_full_content] Aurora Cannabis posted mixed Q1 FY2026 results, facing sales pressure, covenant issues, and looming German regulatory risks. See why ACB stock is downgraded to hold. Read More

[#item_full_content] Aurora Cannabis posted mixed Q1 FY2026 results, facing sales pressure, covenant issues, and looming German regulatory risks. See why ACB stock is downgraded to hold. Read More